178 related articles for article (PubMed ID: 19732748)
1. Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems.
Okada K; Shoda J; Taguchi K; Maher JM; Ishizaki K; Inoue Y; Ohtsuki M; Goto N; Sugimoto H; Utsunomiya H; Oda K; Warabi E; Ishii T; Yamamoto M
Biochem Biophys Res Commun; 2009 Nov; 389(3):431-6. PubMed ID: 19732748
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice.
Okada K; Shoda J; Taguchi K; Maher JM; Ishizaki K; Inoue Y; Ohtsuki M; Goto N; Takeda K; Utsunomiya H; Oda K; Warabi E; Ishii T; Osaka K; Hyodo I; Yamamoto M
Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G735-47. PubMed ID: 18687751
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 protects against furosemide-induced hepatotoxicity.
Qu Q; Liu J; Zhou HH; Klaassen CD
Toxicology; 2014 Oct; 324():35-42. PubMed ID: 24813929
[TBL] [Abstract][Full Text] [Related]
4. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.
Okada K; Warabi E; Sugimoto H; Horie M; Tokushige K; Ueda T; Harada N; Taguchi K; Hashimoto E; Itoh K; Ishii T; Utsunomiya H; Yamamoto M; Shoda J
J Gastroenterol; 2012 Aug; 47(8):924-35. PubMed ID: 22367278
[TBL] [Abstract][Full Text] [Related]
6. Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice.
Reisman SA; Csanaky IL; Aleksunes LM; Klaassen CD
Toxicol Sci; 2009 May; 109(1):31-40. PubMed ID: 19246624
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of nuclear factor-E2-related factor 2 induces biotransformation enzyme and transporter expression in livers of mice with hepatocyte-specific deletion of Kelch-like ECH-associated protein 1.
Cheng Q; Taguchi K; Aleksunes LM; Manautou JE; Cherrington NJ; Yamamoto M; Slitt AL
J Biochem Mol Toxicol; 2011; 25(5):320-9. PubMed ID: 21538727
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 activation enhances biliary excretion of sulfobromophthalein by inducing glutathione-S-transferase activity.
Reisman SA; Csanaky IL; Yeager RL; Klaassen CD
Toxicol Sci; 2009 May; 109(1):24-30. PubMed ID: 19246623
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 induces fibroblast growth factor 21 in diabetic mice.
Furusawa Y; Uruno A; Yagishita Y; Higashi C; Yamamoto M
Genes Cells; 2014 Dec; 19(12):864-78. PubMed ID: 25270507
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism.
Chen P; Li J; Fan X; Zeng H; Deng R; Li D; Huang M; Bi H
Eur J Pharmacol; 2015 Oct; 765():131-9. PubMed ID: 26297978
[TBL] [Abstract][Full Text] [Related]
11. Keap1 inhibition attenuates glomerulosclerosis.
Miyazaki Y; Shimizu A; Pastan I; Taguchi K; Naganuma E; Suzuki T; Hosoya T; Yokoo T; Saito A; Miyata T; Yamamoto M; Matsusaka T
Nephrol Dial Transplant; 2014 Apr; 29(4):783-91. PubMed ID: 24523358
[TBL] [Abstract][Full Text] [Related]
12. Effect of graded Nrf2 activation on phase-I and -II drug metabolizing enzymes and transporters in mouse liver.
Wu KC; Cui JY; Klaassen CD
PLoS One; 2012; 7(7):e39006. PubMed ID: 22808024
[TBL] [Abstract][Full Text] [Related]
13. Nrf2-Keap1 defines a physiologically important stress response mechanism.
Motohashi H; Yamamoto M
Trends Mol Med; 2004 Nov; 10(11):549-57. PubMed ID: 15519281
[TBL] [Abstract][Full Text] [Related]
14. Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis.
Ohkoshi A; Suzuki T; Ono M; Kobayashi T; Yamamoto M
Cancer Prev Res (Phila); 2013 Feb; 6(2):149-59. PubMed ID: 23250896
[TBL] [Abstract][Full Text] [Related]
15. The role of 17β-estradiol in the regulation of antioxidant enzymes via the Nrf2-Keap1 pathway in the livers of CBA/H mice.
Sobočanec S; Šarić A; Mačak Šafranko Ž; Popović Hadžija M; Abramić M; Balog T
Life Sci; 2015 Jun; 130():57-65. PubMed ID: 25818184
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity.
Okawa H; Motohashi H; Kobayashi A; Aburatani H; Kensler TW; Yamamoto M
Biochem Biophys Res Commun; 2006 Jan; 339(1):79-88. PubMed ID: 16293230
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation.
Keleku-Lukwete N; Suzuki M; Otsuki A; Tsuchida K; Katayama S; Hayashi M; Naganuma E; Moriguchi T; Tanabe O; Engel JD; Imaizumi M; Yamamoto M
Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12169-74. PubMed ID: 26371321
[TBL] [Abstract][Full Text] [Related]
18. Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion.
Tanaka N; Ikeda Y; Ohta Y; Deguchi K; Tian F; Shang J; Matsuura T; Abe K
Brain Res; 2011 Jan; 1370():246-53. PubMed ID: 21075092
[TBL] [Abstract][Full Text] [Related]
19. NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice.
Shirasaki K; Taguchi K; Unno M; Motohashi H; Yamamoto M
Hepatology; 2014 Jun; 59(6):2371-82. PubMed ID: 24443206
[TBL] [Abstract][Full Text] [Related]
20. Organic anion transporting polypeptide 1a1 null mice are sensitive to cholestatic liver injury.
Zhang Y; Csanaky IL; Cheng X; Lehman-McKeeman LD; Klaassen CD
Toxicol Sci; 2012 Jun; 127(2):451-62. PubMed ID: 22461449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
